Cardinal Health (CAH) revenue breakdown
By segment, Pharmaceutical and Specialty Solutions is the largest at 92% of fiscal 2026 revenue, growing 8% a year over 9 years.
By region, United States is the largest at 99% of fiscal 2026 revenue, growing 8% a year over 9 years.
Revenue by segment
Fiscal years, as Cardinal Health reports them in its 10-K filings; fiscal 2026 total $254.3B.
| Segments | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmaceutical and Specialty Solutions | $116.5B | $121.2B | $129.9B | $137.5B | $145.8B | $164.6B | $188.8B | $210.0B | $204.6B | $234.8B | 92% |
| GMPD | — | — | — | — | — | $13.3B | $12.2B | $12.4B | $12.6B | $12.7B | 5% |
| Other Operating Segment | — | — | — | — | — | $3.5B | $4.0B | $4.5B | $5.4B | $6.8B | 3% |
| Medical | $13.5B | $15.6B | $15.6B | $15.4B | $16.7B | — | — | — | — | — | — |
Revenue by region
Fiscal years, as Cardinal Health reports them in its 10-K filings; fiscal 2026 total $254.3B.
| Regions | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $125.0B | $132.5B | $141.5B | $148.7B | $157.8B | $179.5B | $203.4B | $225.2B | $221.0B | $252.6B | 99% |
| International | $5.0B | $4.3B | $4.1B | $4.2B | $4.7B | $1.9B | $1.6B | $1.7B | $1.7B | $1.7B | 1% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for CAH.
Open CAH in InvestinglyQuestions
Where does Cardinal Health make its money?
In fiscal 2026, by segment: Pharmaceutical and Specialty Solutions $234.8B, GMPD $12.7B, Other Operating Segment $6.8B.
From Cardinal Health's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.